Concepedia

Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist

Kiyoshi Arai, Tsuyoshi Homma, Yuka Morikawa, Naoko Ubukata, Hiyoyuki Tsuruoka, Kazumasa Aoki, H Ishikawa, Makoto Mizuno, Toshio Sada

European Journal of Pharmacology · 2015 · 133 citations · 33 references

DOI

Concepts

References

33

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Bertram Pitt, Faı̈ez Zannad, Willem J. Remme et al. · New England Journal of Medicine · 1999 · 9.1K citations · Full text

, , +16

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Bertram Pitt, Willem J. Remme, Faı̈ez Zannad et al. · New England Journal of Medicine · 2003 · 4.9K citations · Full text

, , +17

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

Faı̈ez Zannad, John J.V. McMurray, Henry Krum et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text

, , +4

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

Paul Milliez, Xavier Girerd, Pierre‐François Plouin et al. · Journal of the American College of Cardiology · 2005 · 1.5K citations

, , +9

EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION

B. Pitt, W.J. Remme, F Zannad et al. · 2003 · 713 citations

, , +12